Carol Davila University (UMPCD) has completed the purchase of the Quest boutique building, located in central-eastern Bucharest. The transaction was brokered by Crosspoint Real Estate, a Savills associate in Romania.
The building will house the Institute for Research and Development in Genomics. It has a total area of 4,500m2 spanning over eight floors and two underground levels, offering 38 parking spaces. It has state-of-the-art spaces and will be designed to house the national genomics infrastructure. The property was chosen following a rigorous assessment process that involved strict requirements for the architectural design and state-of-the-art technical equipment necessary for genomics research.
"This transaction represents an important step for the progress of medicine and medical research in Romania, and we are proud to be part of this project, the development of the Institute for Research and Development in Genomics.", stated Simona Urse, Associate Director, Office Agency, within Crosspoint Real Estate.
"We are honoured by the collaboration with the Carol Davila University of Medicine and Pharmacy and we are happy that we were able to participate in the development of a new research centre of such magnitude in Bucharest, being aware of the positive impact it will have both on the scientific progress and the community", said Oana Popescu, Head of Residential at Crosspoint Real Estate.
"It is with immense satisfaction and pride that we announce the completion of the purchase of Quest building, an important step in the development of the Institute for Research and Development in Genomics. This purchase represents not only a physical expansion of our campus, but also an expansion of the scientific and medical horizons of Romania. The building will house state-of-the-art laboratories and research spaces, thus contributing to the advancement of research in genomics, bioinformatics and other omic sciences. It will also allow the academic community to participate in high-level research projects using a well-equipped infrastructure. Given the global context in which we find ourselves, when medical and scientific research are more important than ever, this investment underlines the continuous commitment of Carol Davila University to be at the forefront of knowledge and innovation. We are confident that this new acquisition will have a significantly positive impact on the quality of research and healthcare in Romania and abroad. In closing, I would like to thank everyone involved in this ambitious project, including our administrative team and of course the academic community for their continued support. Together, we are building a better and healthier future for everyone", said the Rector of the Carol Davila University of Medicine and Pharmacy, Viorel Jinga, PhD.